Global biodiversity fund falls short as pharmaceutical firms face criticism
The Cali Fund, aimed at raising $1bn annually from pharmaceutical companies for biodiversity conservation, has secured only $7,000.
The Cali Fund, aimed at raising $1bn annually from pharmaceutical companies for biodiversity conservation, has secured only $7,000.